Patient Who Had No Luck With GLP-1 Drugs Found Success With Surgery
Instead, he convinced her to try injections of semaglutide (Wegovy), one of the newer GLP-1 receptor agonists prescribed for weight loss that have received so much media attention and praise for their ...
pharmaphorum6d
Price cut leads NICE to back Novo Nordisk’s obesity drug Saxenda
Novo Nordisk’s Saxenda has been recommended by NICE as a treatment for obesity, ending a 10-year drought in new drug therapies for weight management. The cost-effectiveness agency for England ...